The aim of the study was to assess the effect of the prolonged intake of three b-blocking drugs (propranolol, metoprolol and nebivolol) on the sexual behavior and penile microcirculation of rabbits. Drugs were administered p.o. for 9 weeks and every three weeks in each group (n ¼ 13) one subgroup (n ¼ 7) performed behavioral tests, whereas in the second subgroup (n ¼ 6) penile microcirculation was measured with a laser Doppler flowmeter. The copulation studies revealed significant impairment of sexual function only in the propranolol treated group. The measured behavioral parameters suggest that at a given dose propranolol affects more performance rather than arousal aspects of rabbits' sexual behavior. In the course of the whole study no significant difference was observed among groups in penile blood flow. The data indicate that among the b-blockers given only propranolol interferes with sexual behavior, and that b-blockers do not appear to have a negative effect on penile microcirculation.
Introduction
b-adrenoreceptor blocking drugs are widely used for the treatment of many cardiovascular diseases, such as arterial hypertension, coronary heart disease, heart failure or tachyarrhytmias. 1 They are also beneficial in other diseases, such as hyperthyroidism, psychosomatic disorders, glaucoma and many others. Despite their proven efficacy, the use of b-blocking agents for the treatment of hypertension in USA has decreased since 1992, while the use of calcium channel blockers and angiotensin-converting enzyme inhibitors has increased. 2 Among other factors, the conviction that b-blockers have adverse effects on sexual life may have influenced both patients and physicians to avoid the prescription of these drugs. 3, 4 The results of clinical studies concerning the adverse effects of b-blockers on sexual function are ambiguous. On the one hand, for many years several b-adrenoreceptor blocking drugs have been reported to cause sexual dysfunctions for men. [5] [6] [7] On the other hand, systematically growing evidence from more recent studies shows no correlation between b-blocker therapy and sexual function in male patients. [8] [9] [10] [11] The results of meta-analysis performed by Ko et al. 12 including 15 randomized trials (over 35 000 subjects) of b-blockers used in the treatment of various cardiovascular diseases, have shown that the conventional wisdom that b-blocker therapy is associated with substantial risk of depressive symptoms, fatigue and sexual dysfunction is not supported by data from clinical trials. The possible explanation why in many trials b-blockers show clear negative influence on patients' sexual life can be found in a very interesting study conducted by Silvestri et al. 13 They have demonstrated that patients treated with atenolol, when informed about the drug and its possibly negative influence on sexual life, showed a statistically significant higher number of incidences of erectile dysfunction in comparison to patients unaware of the drug given to them and of its possible adverse effects. The authors suppose that the awareness of and prejudice against the side effects of b-blockers can produce anxiety which in turn may cause erectile dysfunction. This study has exposed limitations of open trials based on patients' reports about their sexual life.
Behavioral tests on animals seem more adequate in this context to study possible adverse effects of drugs on sexual behavior because of absence of psychological factors. In recent years there have been carried out several animal studies with b-blocking drugs. Most of them, however, involved the use of acute drug administration mode which can be useful to study the mechanisms of action, but is not always adequate as a model in the case of patients receiving long-term therapy. In this study, we have tried to assess how chronically orally given b-blockers with various pharmacological properties affect sexual functions in normotensive rabbits. The prolonged drug intake in normotensives could show sexual adverse effects of these drugs without the interaction of various physiological mechanisms caused secondary to hypertension.
Microcirculatory disturbances, oedema and, finally, capillary deposition of fibrin and collagen have been postulated to be the factors producing tissue damage in patients with vasculogenic impotence. The role of b-blockers in peripheral vascular resistance is complex. Cardiodepression caused by b-blockers initially evokes a rise in vascular resistance. After that, the blood pressure always falls parallel with the decline in vascular resistance.
14 In order to assess the influence of b-blockers on penile microcirculation during the current experiment and to find its possible correlations with changes in mating behavior, we have used a non invasive method, the laser Doppler flowmetry.
Materials and methods

Animals
Fifty-two male New Zealand White rabbits in the weight range of 3-4 kg were randomly divided into four experimental groups (n ¼ 13). Three groups received a b-blocking drug, and one was given a placebo. Each group was divided into two subgroups: the rabbits of the first subgroup (n ¼ 7) performed only behavioral testing, while in the second subgroup the penile microcirculation was studied (n ¼ 6). The rabbits were housed in individual steel cages (50 Â 45 Â 40 cm high) under the natural day/ night cycle at room temperature (22-241C) and provided with food and water ad libitum. The females were ovariectomized at least 2 weeks before the use under pentobarbital anesthesia -30 mg/kg (Biowet, Pu"awy, Poland). Oestrus behavior was induced through subcutaneous administration, once per week, of 2.5 mg estradiol valerianate (Jenapharm, Jena, Germany) in 0.25 ml corn oil, which maintained constant receptivity for about 3-4 months. The experiments were performed according to the guidelines for the care and use of laboratory animals after the approval of the local ethics commission.
Drugs b-Adrenoreceptor antagonists were administered daily to the animals of the test groups p.o. by steel gavage for 9 weeks, in two divided doses. Group I received 5 mg/kg/24 h of propranolol (Polfa Warszawa, Warszawa, Poland), group II -5 mg/kg/24 h of metoprolol (Polpharma, Starogard Gdań ski, Poland), and group III -1 mg/kg/24 h of nebivolol (BerlinChemie, Berlin, Germany). Each drug preparation was dissolved in 5 ml saline. The control group received 5 ml saline twice daily.
Behavioral testing
The male rabbits were tested for the occurrence of mating behavior. Only the males ejaculating at least once in three screening tests were used in this experiment. The males were placed in a steel observation cage (100 Â 50 Â 40 cm high) 10 min before the introduction of a receptive female. After the initiation of the test, standard parameters were recorded: mount latency (time from the introduction of the female until the first mount with pelvic thrusting), ejaculation latency (time from the introduction of the female until the first ejaculation), the postejaculatory interval (time from the ejaculation to the next mount), mount frequency (number of mounts), and the ejaculation frequency (number of ejaculations). We also calculated intromission ratio by dividing the number of intromissions by the number of mounts plus the number of intromissions (rabbits ejaculate normally upon every vaginal penetration). The test lasted 10 min. If a given animal was in the postejaculatory interval at this time, the test was continued until the following mount or until the interval exceeded 10 min.
The first records were taken at the time of initiation of the experiment, that is before drug administration (week 0). The tests were then repeated in the third, the sixth and the ninth weeks.
Penile microcirculation study A laser Doppler flowmeter was used to determine penile microcirculation (MBF-3D, Moor Instruments, Devon, UK). The animals were anesthetized with pentobarbital sodium (Biowet, Pu"awy, Poland) at the dose 30 mg/kg i.v. The central ear artery was cannulated for continuous monitoring of arterial blood pressure. At the beginning of the test the penile sheath was manually retracted, and after 10 min of adaptation to room temperature in the laboratory the p4s laser Doppler flow detection probe was positioned in a holder close (2-3 mm) to the dorsal side of the penis. The result of the test was based on the average of arbitrary flow units (flux) within 10 min of the test. The probe was calibrated before each test with flux standard (Moor Instruments). 
Results
There was no statistically significant effect acquired on mount latency, ejaculation latency, postejaculatory interval, or on the proportion of subjects displaying mounts between the experimental groups and control group. Therefore, these data are not shown on the graphs. The significant difference in mating behavior was demonstrated only by the rabbits treated with propranolol. In this group, in the sixth week, only two animals ejaculated during the test and in the ninth week four rabbits, respectively (Table 1) . Ejaculation frequency was lowered slightly in the third week and with statistical significance in the sixth and ninth weeks of propranolol administration (Figure 1 ). However, in the propranolol group there was no significant effect on the proportion of subjects displaying mounts. The male rabbits from this group, even if unable to ejaculate, were still sexually interested in receptive females, which is noticeable from the number of mounts in propranolol group being even higher than in the other groups (Figure 2) . The number of mounts, albeit not significant itself, if combined with the number of intromissions as the intromission ratio, reveals significant lowering in the sixth week of propranolol treatment (Figure 3) . These results, taken into consideration together with the lack of effect on both latencies, the postejaculatory interval and the number of subjects displaying mounts, may suggest that propranolol is affecting rabbits' sexual behavior more due to the impairment of performance than motivation (libido).
The results in the metoprolol treated group reflected similar trends (lower ejaculation number, lower intromission ratio). However, they never exceeded the level of significance. Nebivolol seemed to show the least influence on rabbits' sexual behavior in comparison with the control group.
In the microcirculatory study with a laser Doppler flowmeter no significant differences (Pp0.05) were found in mean flux values among the four groups tested in every week (Figure 4 ). The proportion of subjects displaying ejaculations was evaluated with the Cochran's Q test (*Po0,05). Abbreviations: C, control; P, propranolol; M, metoprolol; N, nebivolol. 
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Discussion
Sexual dysfunction caused by drugs could lead to patients' noncompliance. [15] [16] [17] In the case of b-blockers, which are one of the most often prescribed drugs in many cardiovascular diseases, this could be implicated by increased morbidity and mortality. Therefore, it is very important to exactly determine if and how therapy with these drugs impairs sexual quality of life.
The results of our current study indicate that chronic oral administration of propranolol, but not metoprolol, or nebivolol, is associated with the impairment of male rabbits' sexual behavior. It remains in accordance with other animal studies. In normotensive male rats administration of nonselective b-blockers propranolol or pindolol is associated with inhibition of copulatory behavior, whereas b 1 -selective antagonists labetalol, metoprolol and atenolol show no impact on sexual function. 18, 19 In rats treated for 16 weeks with four antihypertensive agents the propranolol-treated group showed increases in sexual latencies and decrements in frequencies in line with a statistically significant alteration in intracavernous pressure. 20 There are several possible explanations of such properties of propranolol. Apart from their nonselective b-adrenoreceptor blockade, propranolol and pindolol in addition exhibit binding affinity for various 5-HT 1 receptor subtypes, 21 which have been demonstrated in many studies to modify sexual behavior. 22, 23 There is also clinical and experimental evidence for the reduction of testosterone levels in the course of continued medication with propranolol. 24 These various mechanisms may explain why propranolol seems to have more side effects on sexual behavior than other b-blockers.
In all animal studies propranolol was revealed to have an impact on arousal aspect of sexual function, whereas our results are more indicative of the performance impairment (lower ejaculation frequency together with lower intromission ratio and no significant differences in mount latency, ejaculation latency, postejaculatory interval and number of subjects displaying mounts). It is not clear if these differences are caused by the use of other species or can be attributed to other factors. Most studies are performed in acute administration mode, whereas long-term treatment could lead to changes in receptor density or neurotransmitter release both in central and in peripheral structures responsible for sexual behavior. It should also be examined how chronic propranolol treatment affects sexual function in dose-related mode. Last but not least, behavioral measures are not very easily interpretable, particularly when there is a combined drug's influence on both arousal and performance. 25 There is also evidence that propranolol has a negative impact on erectile and ejaculatory reflexes. 26 b-adrenoreceptors, albeit 10 times fewer than a-subtype, 27 are still present in erectile tissue, and may probably have a role in the further increase in arterial inflow in connection with sexual intercourse. 28 In isolated tissue, radioligand studies suggest that they belong to the b 2 -type, 29 which may explain, why impairment of copulatory behavior is caused only by the non-selective propranolol, which b 2 /b 1 ratio (calculated as its K i for b 1 receptor divided by K i for b 2 receptor) is 8.3 whereas this value for metoprolol and nebivolol is 0.43 and 0.02, respectively. 30, 31 There are also potential, but still unknown, mechanisms: interesting results have been obtained in the study of Teixeira et al. 32 which suggests that there is an atypical b-adrenoreceptor subtype in rabbit corpus cavernosum that may be involved in the mechanism of erection. It clearly shows that b-blocker's influence on penile vasculature and, in consequence, on erectile function, needs further investigation.
As for b-blockers' influence on peripheral vasculature, they have been claimed to cause aggravation of intermittent claudication. 33, 34 There are also several case reports describing adverse effects of b-blockers, such as cold extremities, Raynaud phenomenon or peripheral ischemia. [35] [36] [37] Searching for any disturbances in penile superficial vessels resistances associated with b-blocker treatment and their possible correlations with results of behavioral studies, we used a non-invasive method, the laser Doppler flowmetry. 38 Our findings showed that penile microcirculation does not change with longterm b-blocker treatment. Even nebivolol, which produces nitric oxide (NO) mediated vasodilatation, showed no influence on penile microcirculation. There is evidence that suggests that the initially increased vascular resistance may decrease after long-term b-blocking therapy. 39 Cardiodepression caused by b-blockers initially evokes a rise in vascular resistance. Therefore, acute treatment with a b-blocker is not very effective in reducing arterial pressure due to compensatory increase in systemic Influence of prolonged b-blockers treatment B Grotthus et al vascular resistance. This may occur because of baroreceptor reflexes working in conjunction with the removal of b 2 vasodilatory influences that normally offset, to a small degree, a-adrenergic mediated vascular tone. In long-term treatment blood pressure always falls parallel with the decline in vascular resistance. 14 Studies performed with the use of the laser Doppler flowmetry in other than penile regions of skin also showed minor, or even none, effect of b-blockers on the microcirculation. [40] [41] [42] [43] From drugs used in the current study it was nebivolol that had the least influence on the rabbits' sexual behavior. Nevertheless, its potential minor impact on sexual behavior in our study should be interpreted with caution because due to its pharmacokinetic properties (very long half-life time) 1 it was used (as it is used in human therapy) at a lesser dose than propranolol or metoprolol. Nebivolol is a novel generation b-blocking drug, with additional mechanism of action through NO synthesis stimulation. 44 One double blind, randomized study of over 314 human subjects showed no effect of nebivolol or losartan on sexual function. 45 As far as we know, its influence on sexual behavior has not yet been studied on an animal model, which could be interesting because of NO central role in mechanisms of erection.
Results of experimental studies show that the mechanism of potential negative b-blockers' influence on sexual behavior is not yet precisely described and may be unrelated to their b-adrenoreceptor blocking abilities. 19 Drugs from this group differ from one another in many pharmacological, pharmacokinetical and physicochemical properties, which may implicate differences in incidence and strength of various adverse effects. Studies performed on humans and animals show that assigning to b-blockers a label of drugs in general impairing the sexual quality of life may be wrongful. Sexual behavior is a very complex phenomenon that could be affected on many levels. There is, therefore, a need for further exploration of whether and by what mechanisms particular b-blocking drugs influence sexual behavior.
